HA
Hélène Asnagli
Sr Director Pharmacology at Step Pharma
View Hélène's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Sr Director Pharmacology
Present
Company Details
2-10 Employees
Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases.
Step Pharma’s lead program STP938 is a potent, selective, oral inhibitor of CTPS1 with demonstrated potent anti-tumor activity in models of leukemia and lymphoma. STP938 will enter clinical development in 2022 for the treatment of relapsed and refractory T-cell and B-cell lymphoma.
Website
Year Founded
2014
Social Media
Linkedin
Industry
Biotechnology Research, Biotechnology research and development, Research and testing, IT, Internet, R&D, Specialty (except Psychiatric and Substance Abuse) Hospitals, Health Care and Social Assistance
HQ Location
15, Rue Louis et Auguste Lumière
Saint-Genis-Pouilly, Auvergne-Rhône-Alpes 01630, FR
Keywords
oncology therapylead assetkey treatmentkey drugoncology clinical advisorytargeted oncology
Contact Details
- Email AddressH**@step-ph.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Hélène Asnagli in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.